These ideological shifts have raised substantial concerns regarding potential harm that such denial of biological realities could inflict on patients. However, recent academic discourse has escalated these concerns to new levels. A provocative new paper in the journal Qualitative Research in Health titled “Medical uncertainty and reproduction of the ‘normal’: Decision-making around testosterone therapy in transgender pregnancy” by Pfeffer and colleagues propels us further down the road of medical malpractice.
The authors, a group of transgender sociologists and enthusiasts, and healthcare activists, with not one medical degree among them, argue to dramatically move the goal posts of medical ethics, choosing to completely disregard the health, safety, and well-being of the developing fetus, all in the name of “trans” inclusion. Abiding by their paper’s guidance would land us in a vacuum devoid of medical ethics and a seismic shift away from the importance of scientific research and medical evidence in favor of activist directed healthcare.
The authors argue that “gendered” pregnancy care is too focused on helping women have healthy babies, and that it might be okay for transmen to continue taking testosterone during pregnancy despite the known health risks to the fetus and effects on its normal development. The desire for “normal fetal outcomes,” according to the authors, is rooted in a problematic desire “to protect their offspring from becoming anything other than ‘normal’” and “reflect historical and ongoing social practices for creating ‘ideal’ and normative bodies.”